Britain has ordered 100 million doses of the vaccine – enough to vaccinate most of the population – expected to roll out shortly weeks if the batch is approved

Developed by AstraZeneca and Oxford University, the

coronavirus vaccine can prevent more than 70 percent of people from receiving Covid-19 and can be up to 90 percent effective at certain doses, data shows

AstraZeneca and Oxford University announced that their push is effective in preventing many people from getting sick They have been shown to work in different age groups, including the elderly

One of the dosage patterns used by the scientists suggested 90 percent effectiveness when given half a dose followed by another full dose

Another dosage pattern showed 62 percent effectiveness when a full dose was given followed by another full dose

The combined analysis of both dosage regimens resulted in an average effectiveness of 704 percent

Britain has ordered 100 million doses of the Oxford vaccine – enough to vaccinate most of the population – and it is expected to launch in the coming weeks if the sting is approved

In addition, Pfizer and BioNTech order 40 million doses of one shot, which has been shown to be 95 percent effective Another shot from Moderna is 95% effective according to test data

Professor Andrew Pollard, director of the Oxford Vaccine Group and lead investigator of the Oxford Vaccine Trial, said they had developed “an effective vaccine”

“These results show that we have an effective vaccine that will save many lives,” he said. “Excitingly, we have found that one of our dosage regimens can be about 90 percent effective If this dosing regimen is used, more people could be vaccinated with the planned vaccine supply

“Today’s announcement is only possible thanks to the many volunteers in our study and the hard working and talented team of researchers around the world”

He said that no one who received the Oxford vaccine in the studies needed hospital treatment for Covid-19

“We have a vaccine that can protect against coronavirus disease, and most importantly, no one who had the Oxford vaccine has been hospitalized or has severe cases

“So that means if we were to vaccinate people, the results certainly imply that we could stop people from getting serious illnesses and going to the hospital”

His colleague, Professor Sarah Gilbert, Professor of Vaccination Science at Oxford University, said, “Today’s announcement brings us one step closer to the time we can use vaccines to end the havoc caused by SARS-CoV -2 We will continue to work to provide detailed information to regulators. It has been a privilege to be part of this multinational effort that will benefit the whole world ”

Pascal Soriot, CEO of AstraZeneca, said the vaccine’s simple supply chain and charitable promise mean that it will be “affordable and available worldwide”

“The effectiveness and safety of this vaccine confirm that it is highly effective against Covid-19 and has an immediate impact on this public health emergency

“In addition, the vaccine’s simple supply chain and our charitable promise and commitment to widespread, equitable, and timely access means that it will be affordable, available worldwide, and deliver hundreds of millions of doses when approved”

Health Secretary Matt Hancock called the data from AstraZeneca and Oxford University “really encouraging news” but stressed that vaccines must be approved by the Medicines and Health Products Regulatory Agency (MHRA)

“This is really encouraging news on the Oxford AstraZeneca vaccine that we have obviously supported from the start,” he told Sky News

“And I’m really excited to welcome these numbers, these data, which show that the vaccine can be up to 90% effective at the right dose

“Of course, it’s important that the independent regulator, the MHRA, review the data and verify that it is effective and secure”

“But we have ordered 100 million cans and if everything goes well, most of the rollout will take place in the new year””

“So it’s really good news to have two vaccines that are 90% effective”

He tweeted: “Very promising data from Oxford / AstraZeneca Phase III clinical trials We are facing a major scientific breakthrough that could save millions of lives. The UK has secured early access to 100 million doses of its vaccine – in addition to 255 million cans from other developers ”

Peter Horby, Professor of Emerging Infectious Diseases and Global Health at Oxford University, tweeted: “Oxford Jab is far cheaper and easier to store and get to every corner of the world than the other two”

Dr Michael Tildesley, Associate Professor of Infectious Disease Modeling at the University of Warwick, told Times Radio, “It is absolutely excellent news about the Oxford vaccine as this is really the vaccine that the government has had high hopes for resources – us have ordered 100 million doses of the Oxford vaccine ”

Oxford Vaccine

World News – UK – Oxford vaccine is 70% effective and can be as high as 90% in certain doses